The boron neutron capture therapy system market focuses on specialized equipment and compounds used in BNCT, a targeted cancer treatment that combines boron-10 delivery agents with neutron irradiation to selectively destroy tumor cells while sparing healthy tissue. BNCT is particularly promising for recurrent, locally advanced, or radioresistant tumors. The market was valued at around USD 800...